Welcome to our dedicated page for Xebra Brands news (Ticker: XBRAF), a resource for investors and traders seeking the latest updates and insights on Xebra Brands stock.
Xebra Brands Ltd. reports news around its international cannabis business, cannabis-derived wellness products, and the ELEMENTS™ product line. Company updates also cover its Mexico authorization to import, cultivate, manufacture, and sell cannabis with less than 1% THC, along with partnership activity in North America.
Recent disclosures have centered on reporting-status matters, including delayed annual and interim financial filings, management and failure-to-file cease trade orders, exchange trading status, governance changes, and capital-structure actions such as share consolidation updates.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) has received a court extension from the Mexican Health Regulatory Agency (COFEPRIS) to grant cannabis authorizations, now expected by the week of February 6. These authorizations will focus on cannabis with low levels of THC, primarily for hemp products and CBD sales. The company also announces significant management changes, including the resignation of founder Robert Giustra as Chairman to pursue mining ventures, along with CFO Andrew Yau and Corporate Secretary Daniela Freitas. Rodrigo Gallardo is appointed as the interim CFO and Corporate Secretary.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) announces a favorable ruling from a District Court regarding cannabis authorizations in Mexico. The court dismissed a resolution by COFEPRIS, the Mexican health regulatory agency, as insufficient. It ordered COFEPRIS to issue full authorizations within three business days, although delays are anticipated due to holiday closures. The authorizations will apply to low-THC cannabis, focusing on hemp cultivation and CBD products, with potential opportunities in hemp plastics.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) has announced progress regarding cannabis authorizations in Mexico. The Mexican Health Regulatory Agency, COFEPRIS, has notified Xebra Mexico that it has complied with a Supreme Court mandate for cannabis authorizations. However, Xebra asserts that COFEPRIS has not fully met this mandate and has sought federal judicial intervention. The authorizations will mainly pertain to low-THC cannabis (under 1%) for hemp cultivation and CBD products. Delays in the authorization process are anticipated due to the lack of legal precedent in Mexico.